Sodium vs Potassium Education to Improve Vascular Health
Florida State University · with United States Department of Agriculture (USDA) · NCT07221448
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 32
- US sites recruiting
- 1
- Study start
- April 20, 2026
- Record last updated
- April 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to determine if a self-selected high potassium diet is easier to achieve and more effective at improving vascular health than a low sodium diet in generally healthy young adults who typically consume more than the recommended amount of sodium. The main questions it aims to answer are:
- Is it easier for young adults to increase their potassium intake, rather than reduce their sodium intake?
- Is a self-selected high potassium diet better at improving vascular health compared to a self-selected low sodium diet?
Researchers will compare the effectiveness of an education-based intervention centered only on increasing dietary potassium intake against an education-based intervention centered only on reducing dietary sodium intake.
Participants will be randomly assigned to receive comprehensive dietary education on adopting either a high-potassium diet or a low-sodium diet.
Education will be delivered in four weekly one-on-one sessions. Following the four-week education period, participants will be encouraged to change their diet based on what they have learned. Measures of dietary compliance (urine samples and diet records) and cardiovascular health (blood pressure, endothelial function) will be assessed at two, four, and six months post-education.
Being studied: High potassium dietary education/counseling; Low sodium dietary education/counseling
Conditions: Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willing and able to attend in-person laboratory visits
- Usual sodium intake ≥3,000 mg/d for females and ≥4,000 mg/d for males
- Usual potassium intake ≤2,500 mg/d in females and ≤3,000 mg/d in males
Exclusion Criteria
- BMI ≥35 kg/m2
- Seated blood pressure ≥130/80 mmHg
- Current diagnosis or history of diabetes, renal disease, cancer, cardiovascular disease, or major cardiovascular event (e.g. heart attack or stroke)
- Current or recent use of a diuretic (within the past 6 months)
- Elevated blood lipids (LDL cholesterol ≥190 mg/dL)
- Elevated serum potassium level (>5.1 mmol/L)
- Elevated BUN (>22 mg/dL)
- Elevated creatinine (>1.2 mg/dL)
- Low eGFR (\<90 mL/min/1.73 m²)
- Current or recent use of tobacco, nicotine, or illicit drugs
- Radical hysterectomy or oophorectomy (females)*
- Pregnant or lactating
- Following a weight-loss diet, or intending to gain or lose weight during the study period
Recruiting US locations
Florida State University
Tallahassee, FL 32304
Site contact: Andrea Lobene, PhD, RD, LD · 850-644-1829 · alobene@fsu.edu
Study contacts (from the official record)
- Andrea Lobene, PhD, RD, LD · 850-644-1829 · alobene@fsu.edu
- FSU Ann's College · 850-644-6685
Similar studies in Florida
All heart & blood pressure studies in Florida →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Orlando, FL + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
Shanghai CureGene Pharmaceutical Co., Ltd.
- Location
- Miami, FL
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Novartis Pharmaceuticals
- Location
- Bradenton, FL + 4 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Clearwater, FL + 30 other US sites
- Eligibility basics
- Ages 65+